Biotech entity
Every one of those 2 sits in a single category, pharma. Of the tracked stories, 2 of 2 also mention India, the most common co-covered peer. Across an 18-day span, the pace is roughly 0.8 stories per week. Their average consequence score of 5.5 runs below the beat's 6.7 for that window.
Last mentioned: Jul 28, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 2 sits in a single category, pharma. Of the tracked stories, 2 of 2 also mention India, the most common co-covered peer. Across an 18-day span, the pace is roughly 0.8 stories per week. Their average consequence score of 5.5 runs below the beat's 6.7 for that window. Source depth averages 3 original sources per story, versus 5.6 across the same-window beat baseline. We currently track 2 Biotech stories that mention Waiel Awwad, published between July 11, 2026 and July 28, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 101 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Waiel Awwad. Shared-story counts are live from our verified record — not editorial picks.
As Sudan rebuilds, it is inviting Indian pharmaceutical companies to move beyond supply into local manufacturing and R&D, leveraging the existing 51% import market share to establish production hubs.
Source: indiagazette.com · zimbabwestar.com
India's 51% share of Sudan's pharmaceutical imports becomes a launchpad for direct investment, with local manufacturing and regulatory collaboration on the table as Sudan recovers from war. The roundtable signals a strategic expansion from generics exports to in-country pharma production.
Source: iraqsun.com · news.webindia123.com
Waiel Awwad is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
